AVDR Avedro Inc

22.67
+0.68  (+3%)
Previous Close 21.99
Open 22
Price To Book 7.76
Market Cap 388,452,354
Shares 17,135,084
Volume 252,197
Short Ratio
Av. Daily Volume 176,856

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 trial to be initiated 1H 2019.
AVDR
Presbyopia
Phase 3 data due 2H 2020.
KXL system
Progressive keratoconus

Latest News

  1. Shareholder Investigation Alert: Halper Sadeh LLP is Investigating Whether the Sale of These Companies is Fair to Shareholders - WAIR, AVDR, PSDO
  2. MERGER ALERT – VSI, AVDR, and CDOR: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies
  3. AVEDRO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avedro, Inc. - AVDR
  4. TRCB, AVDR, CBM, and NCI SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts
  5. MERGER ALERT –NCI, AVDR, and CBM: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies
  6. Avedro Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Avedro, Inc. is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – AVDR
  7. URGENT: Monteverde & Associates PC is Investigating the Following Transaction
  8. Avedro, Inc. (AVDR) Q2 2019 Earnings Call Transcript
  9. AVEDRO, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Merger
  10. Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Avedro, Inc. (NASDAQ: AVDR) on Behalf of Avedro Shareholders and Encourages Avedro Investors to Contact the Firm
  11. Avedro and Glaukos Join Forces
  12. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Avedro, Inc. to Glaukos Corporation is Fair to Shareholders
  13. The Daily Biotech Pulse: Glaukos To Buy Avedro, Mixed Adcom Vote For Gilead, Dynavax Offering
  14. Avedro, Inc. Announces Second Quarter 2019 Financial Results
  15. Glaukos and Avedro Announce Definitive Acquisition Agreement
  16. Avedro, Inc. to Report Second Quarter 2019 Financial Results on August 8, 2019
  17. Were Hedge Funds Right About Flocking Into Avedro, Inc. (AVDR) ?
  18. How Many Avedro, Inc. (NASDAQ:AVDR) Shares Do Institutions Own?
  19. Avedro (AVDR) Hits a 52-Week High on Solid Growth Prospects
  20. Avedro, Inc. to Present at the Guggenheim MedTech Disruptors Summit